Catalog No.S1380 Synonyms: ABT-378

Lopinavir Chemical Structure

Molecular Weight(MW): 628.8

Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM in a cell-free assay.

Size Price Stock Quantity  
In DMSO USD 82 In stock
USD 90 In stock
USD 570 In stock
USD 970 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 7 Publications

2 Customer Reviews

  • Low-micromolar amounts of chloroquine, chlorpromazine, loperamide, and lopinavir inhibit MERS-CoV-induced cytopathology. Huh7 cells in 96-well plates were infected with MERS-CoV isolate EMC/2012 (MOI, 0.005) in the presence of 0 to 20 uM LPV. Cells were incubated for 2 days, and cell viability was monitored using an MTS assay. In addition, the potential toxicity of compound treatment only was monitored in parallel mock-infected Huh7 cell cultures. Graphs show the results (averages and standard deviations [SD]) of a representative experiment that was performed in quadruplicate. All experiments were repeated at least twice. For each compound, the calculated EC50, CC50, and SI values are given.

    Antimicrob Agents Chemother 2014 58(8), 4875-84. Lopinavir purchased from Selleck.

    Sodium butyrate and lopinavir treatment represent pharmacological aging models that reproduce key properties of cellular aging. LLC-PK1 cells were incubated with vehicle (controls), sodium butyrate or lopinavir and assessed for different indicators of aging. (A) The number of cells that scored positive for SA-β-galactosidase activity increased significantly upon treatment with sodium butyrate or lopinavir. Data are shown for three independent experiments as average + SEM. Results were normalized to controls and depicted as arbitrary units (AU). (B) Sodium butyrate and lopinavir increase cell size, cause nuclear dysmorphy, reduce cell proliferation, while lamin A becomes more abundant. Confocal images were acquired for 5-ethynyl-2′-deoxyuridine (EdU) and lamin A (Materials and methods). Representative images are shown for control and treated samples. Scale bar, 20 μm. (C) Nuclear fluorescence was quantified for EdU and lamin A for at least three independent experiments. Pixel intensities were measured for > 100 cells for each experiment per condition. NaBu, sodium butyrate, D, DMSO, Lopi, lopinavir. **, p < 0.01; ***, p < 0.001.

    Biochim Biophys Acta, 2017, 1864(3):475-486. Lopinavir purchased from Selleck.

Purity & Quality Control

Choose Selective HIV Protease Inhibitors

Biological Activity

Description Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM in a cell-free assay.
HIV protease [1]
(Cell-free assay)
1.3 pM(Ki)
In vitro

Lopinavir binds to mutant HIV protease (V82A, V82F and V82T) with Ki of 4.9 pM, 3.7 pM and 3.6 pM, respectively. Lopinavir inhibits 93% of wild-type HIV protease activity at 0.5 nM. Lopinavir inhibits HIV protease activity in the absence and presence of 50% HS with EC50 of 17 nM and 102 nM, respectively, in MT4 cells. [1] Lopinavir is converted to several metabolites in an NADPH-dependent manner in liver microsomes with the primary metabolites M-3 and M-4. [2] Lopinavir is a potent inhibitor of Rh123 efflux in Caco-2 monolayers with IC50 of 1.7 mM. Lopinavir exposure (72 hours) in LS 180V cells reduces the content of intracellular Rh123. Lopinavir induces P-glycoprotein immunoreactive protein and messenger RNA levels in LS 180V cells. [3] Lopinavir inhibits subtype C clone C6 with IC50 of 9.4 nM. [4] Lopinavir inhibits CYP3A with IC50 of 7.3 mM in human liver microsomes, while produces negligible or weak inhibition of human CYP1A2, 2B6, 2C9, 2C19 and 2D6. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MT2 cells NV74dZVUTnWwY4Tpc44h[XO|YYm= M{LOZWFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JGhKXjJiRVjPJIlvKE2WMjDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHB{NDDHZYcheHKxdHXpckBmgHC{ZYPzbY9vKGK7IF3UWEBie3OjeTygSWM2OD1yLkCwNlYh|ryP MYCxO|M4OThzMR?=
HEK293 cells M4DiW2Z2dmO2aX;uJIF{e2G7 MWG0PEBp M4LPRWFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JJdqdGRidInw[UBJUVZzIF7MOE0{KGmwIFjFT|I6OyClZXzsd{Bi\nSncjC0PEBpenNiYomgdoVxdGmlYYTpc44u\GWoZnXjeIl3\SCudXPp[oVz[XOnIILldI9zfGW{IHflcoUu[mG|ZXSgdIhmdm:2eYDpZ{Bie3OjeTygSWM2OD1yLkCwNlgh|ryP MlvJNVc3Ozh4OUS=
human MT4 cells MUfGeY5kfGmxbjDhd5NigQ>? NEe4R2c2KGSjeYO= MWHBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDITXYzKE2VIHnu[oVkfGWmIHnuJIh2dWGwIF3UOEBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oII\pdpV{KHC{b3T1Z5Rqd25iYX\0[ZIhPSCmYYnzJIJ6KEynboTpMXJVKGGldHn2bZR6KGG|c3H5MEBGSzVyPUCuNFA3KM7:TR?= MWqxO|U4Pjh2OB?=
human PBMC cells MVvGeY5kfGmxbjDhd5NigQ>? NYm0UW9CPSCmYYnz MlXDRY51cX[rcnHsJIFkfGm4aYT5JIFo[Wmwc4SgTGlXOiCPUzDpcoZm[3SnZDDpckBpfW2jbjDQRm1EKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[geolzfXNicILv[JVkfGmxbjDh[pRmeiB3IHThfZMh[nliTHXueIkuWlRiYXP0bZZqfHliYYPzZZktKEWFNUC9NE4xOTVizszN NEnCRZgyPzV5Nki0PC=>

... Click to View More Cell Line Experimental Data

In vivo Lopinavir (10 mg/kg, orally) results in Cmax of 0.8 μg/mL and oral bioavailability of 25% in rats. [1]


Animal Research:[1]
- Collapse
  • Animal Models: Sprague-Dawley-derived rats or cynomolgus monkeys
  • Formulation: Mixture of ethanol-propylene glycol-D5W
  • Dosages: 10 mg/kg
  • Administration: Orally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 126 mg/mL (200.38 mM)
Ethanol 126 mg/mL (200.38 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
30% PEG400+0.5% Tween80+5% propylene glycol
For best results, use promptly after mixing.
30 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 628.8


CAS No. 192725-17-0
Storage powder
in solvent
Synonyms ABT-378

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01700790 Terminated Drug: Lopinavir/ritonavir and ritonavir AIDS|Tuberculosis University of Miami|Oswaldo Cruz Foundation February 2016 Phase 4
NCT01660477 Completed Drug: Isavuconazole|Drug: Lopinavir/ritonavir Pharmacokinetics of Isavuconazole|Pharmacokinetics of Lopinavir/Ritonavir|Healthy Volunteers Astellas Pharma Global Development Inc.|Basilea Pharmaceutica International Ltd|Astellas Pharma Inc June 2012 Phase 1
NCT01581853 Completed Drug: Lopinavir/ritonavir 800 mg / 200mg HIV Daniel Podzamczer|Hospital Universitari de Bellvitge May 2012 Phase 4

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How should I go about proceeding with in vitro work to attain high concentration of the chemical?

  • Answer:

    S1380 Lopinavir can be dissolved in 2% DMSO, 49%PEG and 49%culture medium at 5 mg/ml.

HIV Protease Signaling Pathway Map

Related HIV Protease Products

Tags: buy Lopinavir | Lopinavir supplier | purchase Lopinavir | Lopinavir cost | Lopinavir manufacturer | order Lopinavir | Lopinavir distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID